In our case, cabergoline might have promoted PA, which is consistent with the reported efficacy of cabergoline in inducing tumor shrinkage of non-functioning PitNETs that express D2Rs, including silent PIT1 and SF1 or NULL tumors. This evidence concerns the gene SF1 and neoplasm.